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Background
Japanese encephalitis virus (JEV) is a member of the genus
Flavivirus, family Flaviviridae. Flavivirus NS1 glycopro-
teins are essential proteins, which exhibit a high degree of
sequence homology. The NS1 protein is secreted from
infected cells as a soluble hexamer and can induce protec-
tive immune response in mice against lethal encephalitis.
However, its role in neuroinvasion of JEV remains
unknown. Our aim is to identify the role of NS1 protein
in JEV neuropathogenesis. In this study, we have pro-
duced recombinant JEV NS1 protein in Drosophila S2
cells and have characterized its biochemical, biological
and antigenic properties.
Results
The full-length and N- and C-terminal fragments of NS1
protein of JEV Nakayama strain were amplified from
cDNA and inserted into a pMT vector. These plasmids
were transfected into S2 cell. Limit dilution and cell clon-
ing were carried out to subclone NS1 S2 cells to generate
stable cell lines expressing NS1. Ni-NTA and size exclu-
sion FPLC column were used to purify the secreted pro-
teins. S2 cell expression system provided a high amount of
purified full-length protein (1L supernatant yielded 2~5
mg of protein with purity over 90%). We observed one
form of ~300 kD of NS1 by size exclusion column, corre-
sponding to the hexameric form of full-length NS1. Diges-
tion by Endo H and PNGase F generated a 2~4 kD
decrease of NS1 molecular weight. Study of NS1 binding
to different lectines demonstrated the highly mannose
and hybrid glycosylation forms of NS1 N-glycans. Purified
proteins were used to vaccinate C3H mice and showed
high degree of protection against a challenge of 100 LD50
of JEV. MAbs against NS1 were produced and their specif-
icity in Flavivirus genus was characterized.
Conclusion
These studies contribute to better characterize NS1 pro-
tein produced in S2 cells and to understand its role in neu-
ropathogenesis.
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